Search results for " china"
Article
Can Vaccine Development Be Safely Accelerated?
The latest coronavirus─2019-nCoV, since renamed by the World Health Organization as COVID-19─emerged in December 2019 in Wuhan, China. As of late February 2020, it had sickened tens of thousands a…
Article
Setting Standards for Biotech Therapeutics in India
Pharmacopoeia of the People’s Republic of China, 2010, The state Pharmacopoeia Commission of P.R. China, China Medical Science Press, Beijing, China.
USP, USP 37 NF 32, United States Pharmacopoeia…
Article
Outsourcing Trends in Biopharmaceutical Manufacturing
Over the past decade, BioPlan has found that developing regions, including China, India, and Brazil, as well as the substantial investments in technologies that improve productivity and efficiency are…
Article
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
Geographically, 15 years ago, the industry did not predict the rise in bioprocessing in developing regions such as China and Latin America. In a BioPlan survey of 100 participants at the BIO conferenc…
Article
The Bullish Outlook for Biosimilars
Finally, biosimilars have been on the market in India and China for many years; however, these two countries just recently approved and implemented stricter regulatory guidelines that put a greater em…
Article
Cytiva Invests $500 Million Over 5 Years to Expand Global Capacity
In Asia-Pacific, single-use capacity will triple through a partnership with Wego, a large healthcare technology supplier in China that is already producing consumables for Cytiva in the region.
Cel…
Article
A Diverse Landscape of Patent Issues Seen in the US, UK, and the EU
The situation in other countries varies, with countries like India, Brazil and China being less patent-owner-friendly and Europe being relatively more so; the issues in many countries involve compulso…
Article
Biopharma Seeks Balance
Globalization, the rise of China as a player in the pharmaceutical market, ongoing payor pressure, regulatory reform and initiatives, the biosimilar threat to innovator companies, and a fluctuating in…
Article
Understanding Validation and Technical Transfer, Part 2
…e should the coffee be held, and for how long? How should it be served, in a paper cup, foam cup, or china? Does the cup require insulation? Will take-out be available? If reusable, how will the cups…
Article
Establishment of New Modern Plasma Fractionation Facilities in Asia
It is not inconceivable that over the next decade China will become a major player in the international plasma products space.
Elsewhere in Asia, the Thailand Red Cross, in conjunction with t…